Category Archives: Scientific Sessions
Progressing toward an Artificial Pancreas: Preventing and Treating Low Blood Glucose
An important limitation to development of an artificial pancreas is the danger of low blood glucose caused by insulin infusion. A recent Association-funded study works to overcome this issue and bring artificial pancreas technology closer to reality. Continue reading
Tweet this post
Share on Facebook
Email this post
Posted in About Us, Complications, Life with Diabetes, Research, Scientific Sessions, Stop Diabetes Tagged American Diabetes Association, blood glucose, children with diabetes, diabetes complications, diabetes research, Hypoglycemia, Stop Diabetes, type 1 diabetes
#2014ADA: The Largest Diabetes Meeting in the World
We’re excited to bring you the latest news and research, plus interviews with key thought leaders—and share what it all means for people affected by diabetes. Continue reading
Tweet this post
Share on Facebook
Email this post
Posted in About Us, Ask the Expert, Complications, High-Risk Populations, Research, Scientific Sessions, Statistics, Stop Diabetes Tagged American Diabetes Association, diabetes, diabetes prevention, diabetes research, gestational diabetes, Stop Diabetes, type 1 diabetes, type 2 diabetes
Stay on Top of Breaking Diabetes News from our 73rd Scientific Sessions!
Watch as we report “live” from Scientific Sessions, June 21-25, 2013, at http://diabetes.org/breakingnews. Continue reading
Recap of the 72nd Scientific Sessions
It’s been a week since my colleagues and I returned from Philadelphia, where the American Diabetes Association hosted its 72nd Scientific Sessions — and my mind is still buzzing with all the exciting news, connections and conversations that emerged. It … Continue reading
Scientific Sessions Update: ORIGIN Study Finds No Increased Heart, Cancer Risk from Daily Insulin
BREAKING NEWS: We’ve got more good news about the safety of using insulin. Researchers have reported that daily injections, begun during the early stages of type 2 diabetes, neither increased nor reduced the risk of heart attacks, strokes, cancer or … Continue reading
Scientific Sessions Update: Studies Find No Increased Cancer Risk from Insulin Glargine
BREAKING NEWS: Some very good news today for people who use long-acting insulin glargine, also known by the brand name Lantus. Anna Baker reports the latest from Philadelphia.
Scientific Sessions Update: Arthritis Drug Found to Lower Blood Glucose in Type 2 Patients
BREAKING NEWS: We’ve just learned something really interesting about salsalate, a generic prescription drug related to aspirin that is used to treat inflammation. Researchers have discovered that it may be effective at lowering blood glucose in people with type 2 … Continue reading
